Try our Advanced Search for more refined results

Expert Analysis

A Sign Of Long-Term Improvement Of ANDA Review Process

Law360, New York (February 12, 2014, 3:45 PM EST) -- On Jan. 23, the U.S. Food and Drug Administration announced the establishment of a public docket for comments on improving the completeness and quality of abbreviated new drug application submissions to the agency. Specifically, the FDA is asking how it can reduce the occurrence of common deficiencies in the following aspects: filing, chemistry, sterility, bioequivalence, fatal flaws and drug master files....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!